Climb Bio appointed Dr. Perrin Wilson as Chief Business Officer to strengthen its leadership in developing immune-mediated disease treatments. Climb Bio, Inc. has announced the appointment of Dr.
Oct 26 (Reuters) - Bio-Rad Laboratories (BIO.N), opens new tab on Thursday lowered its annual revenue growth forecast, given the uncertain pace of the biopharma sector's recovery and ongoing macro ...
The Chosun Ilbo on MSN
Huons Merges Huonslab to Strengthen Bio Drug Development
Huons Group is accelerating its focus on pharmaceutical and bio business through restructuring subsidiaries and mergers and acquisitions (M&A). The company is overhauling its existing structure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results